Leah Louisa Thompson, M.D.
This page shows the publications co-authored by Leah Thompson and Amy Blum.
Prognostic significance of cutaneous immune-related adverse events in patients with melanoma and other cancers on immune checkpoint inhibitors. J Am Acad Dermatol. 2022 04; 86(4):886-889.
Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancer. Eur J Cancer. 2021 04; 147:13-16.
Cutaneous toxicities of immune checkpoint inhibitors in patients with altered immunity. J Am Acad Dermatol. 2022 01; 86(1):172-174.
Impact of ethnicity on the diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors. J Am Acad Dermatol. 2021 Mar; 84(3):851-854.
Association between common medication triggers and severity of cutaneous immune-related adverse events. J Am Acad Dermatol. 2021 Apr 18.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.